Production and validation of a good manufacturing practice grade human fibroblast line for supporting human embryonic stem cell derivation and culture
Nilendran PrathalingamLinda FergusonLesley YoungGeorg LietzRachel OldershawLyn HealyAlbert B. CraigHelen ListerRakesh BinaykiaRadhika ShethAlison MurdochMary Herbert
27
Citation
43
Reference
10
Related Paper
Citation Trend
Abstract:
The development of reproducible methods for deriving human embryonic stem cell (hESC) lines in compliance with good manufacturing practice (GMP) is essential for the development of hESC-based therapies. Although significant progress has been made toward the development of chemically defined conditions for the maintenance and differentiation of hESCs, efficient derivation of new hESCs requires the use of fibroblast feeder cells. However, GMP-grade feeder cell lines validated for hESC derivation are not readily available. We derived a fibroblast cell line (NclFed1A) from human foreskin in compliance with GMP standards. Consent was obtained to use the cells for the production of hESCs and to generate induced pluripotent stem cells (iPSCs). We compared the line with a variety of other cell lines for its ability to support derivation and self-renewal of hESCs. NclFed1A supports efficient rates (33%) of hESC colony formation after explantation of the inner cell mass (ICM) of human blastocysts. This compared favorably with two mouse embryonic fibroblast (MEF) cell lines. NclFed1A also compared favorably with commercially available foreskin fibroblasts and MEFs in promoting proliferation and pluripotency of a number of existing and widely used hESCs. The ability of NclFed1A to maintain self-renewal remained undiminished for up to 28 population doublings from the master cell bank. The human fibroblast line Ncl1Fed1A, produced in compliance with GMP standards and qualified for derivation and maintenance of hESCs, is a useful resource for the advancement of progress toward hESC-based therapies in regenerative medicine.Keywords:
Foreskin
Good manufacturing practice
Regenerative Medicine
We have tested in two ways the hypothesis that dermal fibroblasts direct the hyperproliferation of the overlying epidermis in psoriasis. First, culture medium from psoriatic and from normal skin fibroblasts was added to monolayer cultures of foreskin keratinocytes. Second, psoriatic and normal fibroblasts embedded in hydrated collagen lattices were co-cultured with monolayers of foreskin keratinocytes. There was no evidence in either study that psoriatic fibroblast products could stimulate the proliferation of the keratinocytes, or that normal fibroblast products inhibited their proliferation. A positive control for the fibroblasts was provided by leucocyte supernatants, which stimulated keratinocyte proliferation by up to 65%. Our data do not support a primary role for dermal fibroblasts in psoriasis.
Foreskin
Epidermis (zoology)
Dermal fibroblast
Cite
Citations (21)
Objective To investigate the effective and stable transduction of human foreskin fibroblast by lentivirus vector,which can provide a basis for induced pluripotent stem cell research.Methods Human foreskin fibroblast was isolated and cultured with the technique of 0.1% collagenase I digesting.Lentivirus with green fluorescent protein infected cells with three gradients were added into DMEM.Three groups of cells with multiply of infection were added respectively enhanced infection solution after being infected for 48 hours.The expression of green fluorescent proteins and infection efficiency were observed with inverted microscope.Results The model of human foreskin fibroblast was successfully established.The best multiply of infection for lentivirus infecting human foreskin fibroblast was 20,which could achieve 80% infection efficiency.However,enhanced infection solution a kind of infected reagents of polycation was need added in DMEM in order to improve the infection efficiency of lentiviral vectors.Conclusion Lentiviru is easy to infect human foreskin fibroblast and demonstrates a high infection efficiency of human foreskin fibroblast,which is a new vector for iPS technology research.
Foreskin
Transduction (biophysics)
Cite
Citations (0)
Induced pluripotent stem cells (iPSCs) hold great promise for basic research and regenerative medicine. They offer the same advantages as embryonic stem cells (ESCs) and moreover new perspectives for personalized medicine. iPSCs can be generated from adult somatic tissues by over-expression of a few defined transcription factors, including Oct4, Sox2, Klf4, and c-myc. For regenerative medicine in particular, the technology provides great hope for patients with incurable diseases or potentially fatal disorders such as heart failure. The endogenous regenerative potentials of adult hearts are extremely limited and insufficient to compensate for myocardial loss occurring after myocardial infarction. Recent discoveries have demonstrated that iPSCs have the potential to significantly advance future cardiovascular regenerative therapies. Moreover, iPSCs can be generated from somatic cells of patients with genetic basis for their disease. This human iPSC derivates offer tremendous potential for new disease models. This paper reviews current applications of iPSCs in cardiovascular regenerative medicine and discusses progress in modeling cardiovascular diseases using iPSCs-derived cardiac cells.
Regenerative Medicine
KLF4
Cite
Citations (19)
Stem cells are unique pools of cells that are crucial for embryonic development and maintenance of adult tissue homeostasis. The landmark Nobel Prize winning research by Yamanaka and colleagues to induce pluripotency in somatic cells has reshaped the field of stem cell research. The complications related to the usage of pluripotent embryonic stem cells (ESCs) in human medicine, particularly ESC isolation and histoincompatibility were bypassed with induced pluripotent stem cell (iPSC) technology. The human iPSCs can be used for studying embryogenesis, disease modeling, drug testing and regenerative medicine. iPSCs can be diverted to different cell lineages using small molecules and growth factors. In this review we have focused on iPSC differentiation towards cardiac and neuronal lineages. Moreover, we deal with the use of iPSCs in regenerative medicine and modeling diseases like myocardial infarction, Timothy syndrome, dilated cardiomyopathy, Parkinson's, Alzheimer's and Huntington's disease. Despite the promising potential of iPSCs, genome contamination and low efficacy of cell reprogramming remain significant challenges.
Regenerative Medicine
Reprogramming
Cite
Citations (17)
In 2006, Dr. Yamanaka created the induced pluripotent stem cell (iPSC) by reprogramming adult fibroblasts back to an immature, pluripotent state. Effectively bypassing the ethical constraints of human embryonic stem cells, iPSCs have expanded the horizons of regenerative medicine by offering a means to derive autologous patient-matched cells and tissues for clinical transplantation. However, persisting safety concerns must be addressed prior to their widespread clinical application. In this review, we discuss the history of iPSCs, derivation strategies, and current research involving gene therapy and disease modeling. We review the potential of iPSCs for improving a range of cell-based therapies and obstacles to their clinical implementation.
Reprogramming
Regenerative Medicine
Cite
Citations (17)
This chapter contains sections titled: Introduction Sources of Pluripotent Stem Cells Embryonic Stem Cells Somatic Cell Nuclear Transfer Reprogramming Through Cellular Fusion Induced Pluripotent Stem Cells Potential of Pluripotent Cells in Regenerative Medicine Pluripotent Cells for Gene Therapy Future Challenges for Pluripotent Stem Cell-Based Regenerative Medicine References
Regenerative Medicine
Reprogramming
Cite
Citations (0)
Foreskin
Cite
Citations (12)
In the present study, cytotoxicity effects of calprotectin on Human Gingival Fibroblast (HGF) and Human Foreskin Fibroblast (HFFF) were compared. For these evaluations, both cells were exposed to the different concentrations of calprotectin, for 24, 48 and 72 h. Cell proliferation was assessed using MTT assay. Our results revealed that growth inhibition of calprotectin on HGF and HFFF occur in a dose- and time-dependent manner. Results of this investigation showed that sensitivity of HGF cells to cytotoxic effect of human calprotectin was more than HFFF. The results indicate that drug resistance process is different for the two kinds of fibroblast cells.
Foreskin
MTT assay
Cite
Citations (4)
Reprogramming
Regenerative Medicine
Cite
Citations (3)
Regenerative Medicine
Cite
Citations (41)